Victory Capital Management’s Keros Therapeutics KROS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-3,716	Closed	-$216K	–	2507
2024 Q3	$216K	Buy	+3,716	New	+$216K	﹤0.01%	2206
2024 Q2	–	Sell	-3,513	Closed	-$233K	–	2508
2024 Q1	$233K	Buy	+3,513	New	+$233K	﹤0.01%	2182